Literature DB >> 16280359

Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress.

Rene Rodriguez1, Mark Meuth.   

Abstract

Cells respond to DNA replication stress by triggering cell cycle checkpoints, repair, or death. To understand the role of the DNA damage response pathways in determining whether cells survive replication stress or become committed to death, we examined the effect of loss of these pathways on cellular response to agents that slow or arrest DNA synthesis. We show that replication inhibitors such as excess thymidine, hydroxyurea, and camptothecin are normally poor inducers of apoptosis. However, these agents become potent inducers of death in S-phase cells upon small interfering RNA-mediated depletion of the checkpoint kinase Chk1. This death response is independent of p53 and Chk2. p21-deficient cells, on the other hand, produce a more robust apoptotic response upon Chk1 depletion. p21 is normally induced only late after thymidine treatment. In Chk1-depleted cells p21 induction occurs earlier and does not require p53. Thus, Chk1 plays a primary role in the protection of cells from death induced by replication fork stress, whereas p21 mediates through its role in regulating entry into S phase. These findings are of potential importance to cancer therapy because we demonstrate that the efficacy of clinically relevant agents can be enhanced by manipulation of these signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16280359      PMCID: PMC1345677          DOI: 10.1091/mbc.e05-07-0594

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  47 in total

1.  Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response.

Authors:  Melissa T Jack; Richard A Woo; Atsushi Hirao; Alison Cheung; Tak W Mak; Patrick W K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

2.  Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.

Authors:  S B Lee; S H Kim; D W Bell; D C Wahrer; T A Schiripo; M M Jorczak; D C Sgroi; J E Garber; F P Li; K E Nichols; J M Varley; A K Godwin; K M Shannon; E Harlow; D A Haber
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

3.  Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation.

Authors:  M Koi; A Umar; D P Chauhan; S P Cherian; J M Carethers; T A Kunkel; C R Boland
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

4.  p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells.

Authors:  M Gorospe; C Cirielli; X Wang; P Seth; M C Capogrossi; N J Holbrook
Journal:  Oncogene       Date:  1997-02-27       Impact factor: 9.867

5.  The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways.

Authors:  Jacob Falck; John H J Petrini; Bret R Williams; Jiri Lukas; Jiri Bartek
Journal:  Nat Genet       Date:  2002-02-19       Impact factor: 38.330

6.  Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin.

Authors:  Zhiyong Han; Wenyi Wei; Stephen Dunaway; James W Darnowski; Paul Calabresi; John Sedivy; Eric A Hendrickson; Kannan V Balan; Panayotis Pantazis; James H Wyche
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

7.  ATR homolog Mec1 promotes fork progression, thus averting breaks in replication slow zones.

Authors:  Rita S Cha; Nancy Kleckner
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

8.  Different roles for nonhomologous end joining and homologous recombination following replication arrest in mammalian cells.

Authors:  Cecilia Lundin; Klaus Erixon; Catherine Arnaudeau; Niklas Schultz; Dag Jenssen; Mark Meuth; Thomas Helleday
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks.

Authors:  K Avemann; R Knippers; T Koller; J M Sogo
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

10.  Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.

Authors:  Atsushi Hirao; Alison Cheung; Gordon Duncan; Pierre-Marie Girard; Andrew J Elia; Andrew Wakeham; Hitoshi Okada; Talin Sarkissian; Jorge A Wong; Takashi Sakai; Elisa De Stanchina; Robert G Bristow; Toshio Suda; Scott W Lowe; Penny A Jeggo; Stephen J Elledge; Tak W Mak
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

View more
  83 in total

1.  Long Term Aggresome Accumulation Leads to DNA Damage, p53-dependent Cell Cycle Arrest, and Steric Interference in Mitosis.

Authors:  Meng Lu; Chiara Boschetti; Alan Tunnacliffe
Journal:  J Biol Chem       Date:  2015-09-25       Impact factor: 5.157

2.  Deubiquitinating enzyme USP3 controls CHK1 chromatin association and activation.

Authors:  Yu-Che Cheng; Sheau-Yann Shieh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

3.  A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint.

Authors:  Rachel Beckerman; Aaron J Donner; Melissa Mattia; Melissa J Peart; James L Manley; Joaquin M Espinosa; Carol Prives
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

4.  The opposite prognostic significance of nuclear and cytoplasmic p21 expression in resectable gastric cancer patients.

Authors:  Yefei Huang; Weimin Wang; Yansu Chen; Yulin Huang; Jianbing Zhang; Song He; Yongfei Tan; Fulin Qiang; Aiping Li; Oluf Dimitri Røe; Shouyu Wang; Yan Zhou; Jianwei Zhou
Journal:  J Gastroenterol       Date:  2013-10-15       Impact factor: 7.527

Review 5.  Senescence and apoptosis: dueling or complementary cell fates?

Authors:  Bennett G Childs; Darren J Baker; James L Kirkland; Judith Campisi; Jan M van Deursen
Journal:  EMBO Rep       Date:  2014-10-13       Impact factor: 8.807

Review 6.  Exploiting replicative stress to treat cancer.

Authors:  Matthias Dobbelstein; Claus Storgaard Sørensen
Journal:  Nat Rev Drug Discov       Date:  2015-05-08       Impact factor: 84.694

7.  Expression of the p12 subunit of human DNA polymerase δ (Pol δ), CDK inhibitor p21(WAF1), Cdt1, cyclin A, PCNA and Ki-67 in relation to DNA replication in individual cells.

Authors:  Hong Zhao; Sufang Zhang; Dazhong Xu; Marietta Ywt Lee; Zhongtao Zhang; Ernest Yc Lee; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Candidate tumor suppressor BTG3 maintains genomic stability by promoting Lys63-linked ubiquitination and activation of the checkpoint kinase CHK1.

Authors:  Yu-Che Cheng; Tsong-Yu Lin; Sheau-Yann Shieh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

9.  Chk1 suppressed cell death.

Authors:  Mark Meuth
Journal:  Cell Div       Date:  2010-09-02       Impact factor: 5.130

10.  Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1.

Authors:  Mary E Gagou; Pedro Zuazua-Villar; Mark Meuth
Journal:  Mol Biol Cell       Date:  2010-01-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.